Skip to main content

Quadient Powers MedExpress Digital Transformation with Automation of Prescription Workflows

  • MedExpress implements Quadient Impress platform to streamline secure medical correspondence and reduce administrative workload

Paris

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, today announced that MedExpress, a leading UK-based online pharmacy, has implemented Quadient Impress, its cloud-based document automation platform, to streamline the creation and delivery of medical correspondence.

Quadient Impress automates the entire outbound communications process, from document to compliant digital or postal delivery, enabling organisations to digitise manual tasks, ensure complete visibility and maintain regulatory compliance. By reducing the need for paper-based administration, the platform helps organisations lower production costs, cut carbon emissions and reallocate resources to higher-value work. Since its launch in 2013, MedExpress has provided prescription medication for more than 1.5 million customers across the UK. With Quadient Impress now fully integrated into its operations, the company is transforming how it handles patient communications.

Every month, up to a 1 million letters are automatically generated and dispatched through the platform, helping MedExpress reduce paperwork, repetitive manual tasks and costs, increase scalability and efficiencies, and focus more time on high quality patient care.

“Every digital connection is an opportunity to earn trust,” said Duncan Groom, Chief Operating Officer, UK & Ireland, Quadient. “At Quadient, we believe the future of communication lies in combining intelligent automation with transparency and responsibility. With Quadient Impress, we help organisations like MedExpress reimagine how they connect with people: securely, compliantly, and sustainably, while reducing the cost and complexity of managing critical communications. Together, we are shaping a future where technology strengthens relationships and delivers lasting value for both businesses and their customers.”

By adopting Quadient Impress, MedExpress is reinforcing its commitment to secure, compliant and sustainable digital healthcare delivery. The collaboration underscores how automation can simplify regulated processes while strengthening trust between patients, providers and partners.

“We now process thousands of medical letters a day in just a few clicks. Quadient’s solution has eliminated the hassle and errors of manual preparation, reduced our costs and ensured data compliance as well as full visibility from creation to dispatch. It’s become essential to our outbound communications workflow,” said David Voss, Supply Chain Director, MedExpress.

About Quadient®
Quadient is a global automation platform powering secure and sustainable business connections through digital and physical channels. Quadient supports businesses of all sizes in their digital transformation and growth journey, unlocking operational efficiency and creating meaningful customer experiences. Listed in compartment B of Euronext Paris (QDT) and part of the CAC Mid & Small and CAC Technology indices, Quadient shares are eligible for PEA-PME investing. For more information about Quadient, visit www.quadient.com.

Quadient UK press contact:
Emmeline May
Wildfire PR
quadient@wildfirepr.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.